Loading...

Potent Antipneumococcal Activity of Gemifloxacin Is Associated with Dual Targeting of Gyrase and Topoisomerase IV, an In Vivo Target Preference for Gyrase, and Enhanced Stabilization of Cleavable Complexes In Vitro

We investigated the roles of DNA gyrase and topoisomerase IV in determining the susceptibility of Streptococcus pneumoniae to gemifloxacin, a novel fluoroquinolone which is under development as an antipneumococcal drug. Gemifloxacin displayed potent activity against S. pneumoniae 7785 (MIC, 0.06 μg/...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Heaton, Victoria J., Ambler, Jane E., Fisher, L. Mark
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology 2000
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC101612/
https://ncbi.nlm.nih.gov/pubmed/11036032
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!